(NASDAQ: SNY) Sanofi's forecast annual revenue growth rate of 8.18% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 7.31%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.76%.
Sanofi's revenue in 2025 is $46,131,250,000.On average, 6 Wall Street analysts forecast SNY's revenue for 2025 to be $63,495,979,218,085, with the lowest SNY revenue forecast at $58,110,971,277,782, and the highest SNY revenue forecast at $67,064,679,841,726. On average, 6 Wall Street analysts forecast SNY's revenue for 2026 to be $68,099,335,240,565, with the lowest SNY revenue forecast at $61,518,686,910,632, and the highest SNY revenue forecast at $72,588,732,331,157.
In 2027, SNY is forecast to generate $74,034,669,329,813 in revenue, with the lowest revenue forecast at $68,956,635,578,149 and the highest revenue forecast at $76,817,654,569,838.